Physician

Adam Joshua Rosenbaum, MD

According to 2025 Medicare claims, Adam Rosenbaum, MD (NPI: 1760876882) practices pulmonary disease in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is NEW YORK UNIVERSITY (NPI: 1285826438; TIN: 472665045) and primary practice location at 11714-3927. Rosenbaum is affiliated with the Delaware Valley ACO (ACO ID: A2024), participating under the MSSP model.

Rosenbaum's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 562 traditional Medicare patients, billed 1,654 HCPCS/CPT codes, and received $129,438 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 451 prescription claims across 186 beneficiaries totaling $135,727 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 855 claims. Open Payments data shows 7 records totaling $3,542. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $2,607 to $135,727. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	13	13	$1,498
2021	344	844	$93,587
2022	607	1,762	$157,501
2023	584	1,706	$151,146
2024	562	1,654	$129,438

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	11	44	$2,607
2016	13	52	$7,096
2017	19	63	$5,229
2018	N/R	17	$2,993
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	30	60	$11,296
2022	145	392	$125,429
2023	166	435	$148,165
2024	186	451	$135,727

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	94	241	$21,477
2023	190	613	$34,687
2024	266	855	$46,362

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	140	140	$143
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	259	430	$77
94729	Test to examine how well the lungs exchange gases	137	146	$51
94726	Test to determine lung volumes using sensors	132	141	$50
94060	Test to measure expiratory airflow and volume changes before and after medication administration	138	146	$36

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	46	1,980	$41,521
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	930	$19,344
Breo Ellipta	Fluticasone/Vilanterol	36	1,380	$16,845
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	19	810	$12,095
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	660	$9,685

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	13	$13,086
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	11	81	$5,726
E0601	Continuous positive airway pressure (cpap) device	Y	30	160	$4,740
A7032	Cushion for use on nasal mask interface, replacement only, each	N	20	40	$3,484
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	32	60	$2,966

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$3,542	INTUITIVE SURGICAL, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Joshua Rosenbaum, MD?

Tedicare shows public-source Medicare data for Adam Joshua Rosenbaum, MD (NPI 1760876882), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Joshua Rosenbaum, MD have ACO affiliation data?

Adam Joshua Rosenbaum, MD is shown with ACO affiliation data for Delaware Valley ACO (MSSP, ACO ID A2024).

What billing organization is linked to Adam Joshua Rosenbaum, MD?

Adam Joshua Rosenbaum, MD is linked to NEW YORK UNIVERSITY (billing NPI 1285826438) in the available physician profile data.

Does Adam Joshua Rosenbaum, MD have Open Payments data?

Adam Joshua Rosenbaum, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.